133 related articles for article (PubMed ID: 20444752)
1. Adverse events in analgesic treatment with tramadol associated with CYP2D6 extensive-metaboliser and OPRM1 high-expression variants.
Kim E; Choi CB; Kang C; Bae SC;
Ann Rheum Dis; 2010 Oct; 69(10):1889-90. PubMed ID: 20444752
[No Abstract] [Full Text] [Related]
2. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.
Kirchheiner J; Keulen JT; Bauer S; Roots I; Brockmöller J
J Clin Psychopharmacol; 2008 Feb; 28(1):78-83. PubMed ID: 18204346
[TBL] [Abstract][Full Text] [Related]
3. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
Reynolds KK; Ramey-Hartung B; Jortani SA
Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064
[TBL] [Abstract][Full Text] [Related]
4. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.
Stamer UM; Stüber F; Muders T; Musshoff F
Anesth Analg; 2008 Sep; 107(3):926-9. PubMed ID: 18713907
[TBL] [Abstract][Full Text] [Related]
5. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC
Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367
[TBL] [Abstract][Full Text] [Related]
6. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia.
Zhang W; Yuan JJ; Kan QC; Zhang LR; Chang YZ; Wang ZY
Minerva Anestesiol; 2011 Jan; 77(1):33-9. PubMed ID: 21150856
[TBL] [Abstract][Full Text] [Related]
7. [Side effects of tramadol: 12 years of experience in the Netherlands].
Kabel JS; van Puijenbroek EP
Ned Tijdschr Geneeskd; 2005 Apr; 149(14):754-7. PubMed ID: 15835626
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
[TBL] [Abstract][Full Text] [Related]
9. The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6.
Enggaard TP; Poulsen L; Arendt-Nielsen L; Brøsen K; Ossig J; Sindrup SH
Anesth Analg; 2006 Jan; 102(1):146-50. PubMed ID: 16368820
[TBL] [Abstract][Full Text] [Related]
10. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol.
Orliaguet G; Hamza J; Couloigner V; Denoyelle F; Loriot MA; Broly F; Garabedian EN
Pediatrics; 2015 Mar; 135(3):e753-5. PubMed ID: 25647677
[TBL] [Abstract][Full Text] [Related]
11. Codeine and tramadol analgesic efficacy and respiratory effects are influenced by CYP2D6 genotype.
Stamer UM; Stüber F
Anaesthesia; 2007 Dec; 62(12):1294-5; author reply 1295-6. PubMed ID: 17991273
[No Abstract] [Full Text] [Related]
12. CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia Patients.
Nasare NV; Banerjee BD; Suryakantrao Deshmukh P; Mediratta PK; Saxena AK; Ahmed RS; Bhattacharya SN
Am J Ther; 2016; 23(3):e697-707. PubMed ID: 23567787
[TBL] [Abstract][Full Text] [Related]
13. Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics.
Saiz-Rodríguez M; Ochoa D; Román M; Zubiaur P; Koller D; Mejía G; Abad-Santos F
Pharmacogenomics; 2020 Jul; 21(10):663-675. PubMed ID: 32538291
[TBL] [Abstract][Full Text] [Related]
14. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice.
Raffa RB; Stone DJ
J Pharmacol Exp Ther; 2008 May; 325(2):500-6. PubMed ID: 18292293
[TBL] [Abstract][Full Text] [Related]
15. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers.
Li Q; Wang R; Guo Y; Wen S; Xu L; Wang S
J Clin Pharm Ther; 2010 Apr; 35(2):239-47. PubMed ID: 20456744
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of tramadol in children].
Saudan S; Habre W
Ann Fr Anesth Reanim; 2007 Jun; 26(6):560-3. PubMed ID: 17524604
[TBL] [Abstract][Full Text] [Related]
17. Modelling the pharmacokinetics of tramadol: on the difference between CYP2D6 extensive and poor metabolizers.
Di Patti F; Fanelli D; Pedersen RS; Giuliani C; Torricelli F
J Theor Biol; 2008 Oct; 254(3):568-74. PubMed ID: 18640130
[TBL] [Abstract][Full Text] [Related]
18. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
Halling J; Weihe P; Brosen K
Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
[TBL] [Abstract][Full Text] [Related]
19. [Side effects of opioid and gene variants].
Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N
Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433
[TBL] [Abstract][Full Text] [Related]
20. The hypoalgesic effect of tramadol in relation to CYP2D6.
Poulsen L; Arendt-Nielsen L; Brøsen K; Sindrup SH
Clin Pharmacol Ther; 1996 Dec; 60(6):636-44. PubMed ID: 8988065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]